REFERENCES
- Su CF, Kao SJ, Chen HI. Acute respiratory distress syndrome and lung injury: pathogenetic mechanism and therapeutic implication. World J Crit Care Med. 2012;1:50–60.
- Christaki E, Lazaridis N, Opal SM. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis? Curr Opin Infect Dis. 2012;25:304–311.
- Guo WA, Knight PR, Raghavendran K. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome. Intens Care Med. 2012;38:1588–1598.
- Hu D, Yang X, Xiang Y, et al. Inhibition of toll-like receptor 9 attenuates sepsis-induced mortality through suppressing excessive inflammatory response. Cell Immunol. 2015;295:92–98.
- Tsao CM, Wu CC. Modulating effects of ketamine on inflammatory response in sepsis. Acta Anaesth Taiwan. 2012;50:145–146.
- Liu FL, Chen TL, Chen RM. Mechanisms of ketamine-induced immunosuppression. Acta Anaesth Taiwan. 2012;50:172–177.
- Yu M, Shao D, Feng X, et al. Effects of ketamine on pulmonary TLR4 expression and NF-kappa-B activation during endotoxemia in rats. Methods Find Exp Clin Pharmacol. 2007;29:395–399.
- Yu M, Shao D, Liu J, et al. Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis. Int Immunopharmacol. 2007;7:1076–1082.
- Yang J, Li W, Duan M, et al. Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats. Inflamm Res. 2005;54:133–137.
- Heidemann SM, Glibetic M. Heat stress protects against lung injury in the neutropenic, endotoxemic rat. Inflammation. 2005;29:47–53.
- Gonzales JN, Gorshkov B, Varn MN, et al. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2014;306:L497–L507.
- Yu M, Shao D, Yang R, et al. Effects of ketamine on pulmonary inflammatory responses and survival in rats exposed to polymicrobial sepsis. J Pharm Pharm Sci. 2007;10:434–442.
- Feng G, Sun B, Li TZ. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway. Int Immunopharmacol. 2015;26:392–400.
- Tianzhu Z, Shumin W. Esculin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of TLR/NF-kappaB pathways. Inflammation. 2015;38:1529–1536.
- Filgueiras LR Jr, Martins JO, Serezani CH, et al. Sepsis-induced acute lung injury (ALI) is milder in diabetic rats and correlates with impaired NFkB activation. PLoS One. 2012;7:e44987.
- Gokcinar D, Ergin V, Cumaoglu A, et al. Effects of ketamine, propofol, and ketofol on proinflammatory cytokines and markers of oxidative stress in a rat model of endotoxemia-induced acute lung injury. Acta Biochim Pol. 2013;60:451–456.
- Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461.
- Ali MF, Driscoll CB, Walters PR, et al. Beta-glucan-activated human B lymphocytes participate in innate immune responses by releasing proinflammatory cytokines and stimulating neutrophil chemotaxis. J Immunol. 2015;195:5318–5326.
- Chytilova M, Nemcova R, Gancarcikova S, et al. Flax-seed oil and Lactobacillus plantarum supplementation modulate TLR and NF-kappaB gene expression in enterotoxigenic Escherichia coli challenged gnotobiotic pigs. Acta Vet Hung. 2014;62:463–472.
- Garcia-Ramirez M, Hernandez C, Palomer X, et al. Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-kappaB activity. Acta Diabetol. 2016;53:109–118.
- Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol. 2003;284:C870–C879.
- Levy RM, Mollen KP, Prince JM, et al. Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1538–R1544.